Perspective · 5 Feb 2026
Subjects
Pharmaceutical SciencesSimilar by topic
Conference abstract · 27 Aug 2018
EFdA: A very excellent anti-HIV modified nucleosides - from design to the current results of clinical trials
Conference abstract · 24 Aug 2018
EFdA: An extremely excellent anti-HIV nucleoside from design to the current clinical trials results
Conference abstract · 11 Sep 2017
More is not better: The result from a US government sponsored multi-center randomized international clinical trial to prevent tuberculosis in HIV/AIDS population
Conference abstract · 20 Feb 2017
A reasonable hope to cure HIV with the Tat Oyi vaccine: Results and follow up of a double blinded randomized phase I/IIa clinical trial in France
More from this journal
The newest in Journal of Clinical Trials.
Case report · 10 Aug 2026
Tuberculosis Associated Spondylolisthesis and Radiculopathy
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sara Drew”

